Aslan Pharmaceuticals Ltd ADR
(ASLN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -12,419 | N/A | -16,971 | -11,017 |
| Depreciation Amortization | N/A | 142 | N/A | 298 | 225 |
| Accounts receivable | N/A | N/A | N/A | N/A | -13 |
| Accounts payable and accrued liabilities | N/A | -273 | N/A | 448 | 358 |
| Other Working Capital | N/A | -1,379 | N/A | -98 | -55 |
| Other Operating Activity | 0 | -553 | 0 | 1,270 | 487 |
| Operating Cash Flow | $N/A | $-14,482 | $N/A | $-15,053 | $-10,014 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -4 | N/A | -4 | -5 |
| Purchase Of Investment | N/A | -17 | N/A | 5 | -1 |
| Purchase Sale Intangibles | N/A | -12 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -12 | 0 | 0 | 0 |
| Investing Cash Flow | $N/A | $-33 | $N/A | $1 | $-5 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -3,250 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 102,346 | N/A | 7,643 | N/A |
| Other Financing Activity | 0 | -4,785 | 0 | -470 | -124 |
| Financing Cash Flow | $N/A | $94,311 | $N/A | $7,173 | $-124 |
| Beginning Cash Position | N/A | 14,324 | N/A | 22,203 | 22,203 |
| End Cash Position | N/A | 94,120 | N/A | 14,324 | 12,060 |
| Net Cash Flow | $N/A | $79,796 | $N/A | $-7,879 | $-10,143 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -14,482 | N/A | -15,053 | -10,014 |
| Capital Expenditure | N/A | -4 | N/A | -5 | -5 |
| Free Cash Flow | 0 | -14,486 | 0 | -15,058 | -10,019 |